| Sources | Names Used |
|---|---|
| CCLE, GDSC1000, FIMM | Nilotinib |
| CTRPv2 | nilotinib |
| PharmacoGx | Nilotinib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
| Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
| Pubchem: | 644241 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIM1 | CCLE | pan-cancer | AAC | 0.32 | 4e-09 |
| mRNA | HLA-DPA1 | CCLE | pan-cancer | AAC | -0.38 | 7e-09 |
| mRNA | LCP2 | CCLE | pan-cancer | AAC | 0.36 | 8e-09 |
| mRNA | PABPC4L | CCLE | pan-cancer | AAC | 0.29 | 8e-09 |
| mRNA | PTGDR2 | CCLE | pan-cancer | AAC | 0.28 | 9e-09 |
| mRNA | SOCS2 | CCLE | pan-cancer | AAC | 0.27 | 1e-08 |
| mRNA | GRAP2 | CCLE | pan-cancer | AAC | 0.3 | 1e-08 |
| mRNA | TMEM217 | CCLE | pan-cancer | AAC | 0.28 | 1e-08 |
| mRNA | GYPA | CCLE | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | TIGAR | CCLE | pan-cancer | AAC | -0.28 | 2e-08 |
